# Different Doses of Rosuvastatin Therapy on Regression of Critical Coronary Atherosclerosis in ACS Patients

> **NCT02420899** · NA · UNKNOWN · sponsor: **Beijing Friendship Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** rosuvastatin

## Key facts

- **NCT ID:** NCT02420899
- **Lead sponsor:** Beijing Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-04
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2015-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02420899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02420899, "Different Doses of Rosuvastatin Therapy on Regression of Critical Coronary Atherosclerosis in ACS Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02420899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*